{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:23:54Z","timestamp":1788575034781,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,24]],"date-time":"2015-05-24T00:00:00Z","timestamp":1432425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10549-015-3434-z","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T04:48:05Z","timestamp":1432529285000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials"],"prefix":"10.1007","volume":"152","author":[{"given":"Sasha","family":"Mazzarello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed F. K.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,24]]},"reference":[{"issue":"6","key":"3434_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","volume":"13","author":"DW Sturdee","year":"2010","unstructured":"Sturdee DW, Panay N, International Menopause Society Writing Group (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13(6):509\u2013522","journal-title":"Climacteric"},{"issue":"3","key":"3434_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/13697137.2012.756466","volume":"16","author":"A Sinha","year":"2013","unstructured":"Sinha A, Ewies AA (2013) Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric 16(3):305\u2013312","journal-title":"Climacteric"},{"key":"3434_CR3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/978-3-642-45769-2_38","volume":"152","author":"PA Ganz","year":"1998","unstructured":"Ganz PA, Rowland JH, Meyerowitz BE et al (1998) Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res 152:396\u2013411","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"3434_CR4","doi-asserted-by":"crossref","first-page":"26e1","DOI":"10.1016\/j.ajog.2010.08.035","volume":"204","author":"J Baumgart","year":"2011","unstructured":"Baumgart J, Nilsson K, Stavreus-Evers A et al (2011) Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol 204(1):26e1\u201326e7","journal-title":"Am J Obstet Gynecol"},{"issue":"9869","key":"3434_CR5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10\u00a0years versus stopping at 5\u00a0years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805\u2013816","journal-title":"Lancet"},{"key":"3434_CR6","first-page":"CD001500","volume":"4","author":"J Suckling","year":"2006","unstructured":"Suckling J, Lethaby A, Kennedy R (2006) Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 4:CD001500","journal-title":"Cochrane Database Syst Rev"},{"issue":"9407","key":"3434_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","volume":"363","author":"L Holmberg","year":"2004","unstructured":"Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer\u2014is it safe?), a randomised comparison: trial stopped. Lancet 363(9407):453\u2013455","journal-title":"Lancet"},{"issue":"7","key":"3434_CR8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","volume":"97","author":"E Schoultz von","year":"2005","unstructured":"von Schoultz E, Rutgvist LE, Stockholm Breast Cancer Study Group (2005) Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 97(7):533\u2013535","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3434_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","volume":"49","author":"M Fahlen","year":"2013","unstructured":"Fahlen M, Fornander T, Johansson H et al (2013) Hormone replacement therapy after breast cancer: 10\u00a0year follow up of the Stockholm randomised trial. Eur J Cancer 49(1):52\u201359","journal-title":"Eur J Cancer"},{"issue":"3","key":"3434_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1634\/theoncologist.2007-0234","volume":"13","author":"M Trinkaus","year":"2008","unstructured":"Trinkaus M, Chin S, Wolfman W et al (2008) Should urogenital atrophy in breast cancer survivors be treated with topical estrogens? Oncologist 13(3):222\u2013231","journal-title":"Oncologist"},{"issue":"2","key":"3434_CR11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","volume":"9","author":"SN Chin","year":"2009","unstructured":"Chin SN, Trinkaus M, Simmons C et al (2009) Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clin Breast Cancer 9(2):108\u2013117","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"3434_CR12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00520-005-0847-y","volume":"13","author":"MC Gainford","year":"2005","unstructured":"Gainford MC, Simmons C, Nguyen H et al (2005) A practical guide to the management of menopausal symptoms in breast cancer patients. Support Care Cancer 13(8):573\u2013578","journal-title":"Support Care Cancer"},{"key":"3434_CR13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0378-5122(95)00956-6","volume":"22","author":"G Bachmann","year":"1995","unstructured":"Bachmann G (1995) Urogenital ageing: an old problem newly recognized. Maturitas 22:S1\u2013S5","journal-title":"Maturitas"},{"key":"3434_CR14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/gme.0b013e31816c5541","volume":"15","author":"R Hess","year":"2008","unstructured":"Hess R, Austin RM, Dillon S et al (2008) Vaginal maturation index self-sample collection in mid-life women: acceptability and correlation with physician-collected samples. Menopause 15:726\u2013729","journal-title":"Menopause"},{"issue":"2","key":"3434_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","volume":"55","author":"LJ Fallowfield","year":"1999","unstructured":"Fallowfield LJ, Leaity SK, Howell A et al (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55(2):189\u2013199","journal-title":"Breast Cancer Res Treat"},{"key":"3434_CR16","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:5928","journal-title":"BMJ"},{"issue":"8","key":"3434_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clon.2012.06.009","volume":"24","author":"CE Simmons","year":"2012","unstructured":"Simmons CE, Kuchuk I, Freedman OC et al (2012) Are Estring(R) and Vagifem(R) equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aromatase inhibitor therapy? Clin Oncol (R Coll Radiol) 24(8):128\u2013129","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"3434_CR18","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/AOG.0000000000000203","volume":"123","author":"MF Goetsch","year":"2014","unstructured":"Goetsch MF, Lim JY, Caughey AB (2014) A solution for dyspareunia in breast cancer survivors. Obstet Gynecol 123(5):1S","journal-title":"Obstet Gynecol"},{"issue":"3","key":"3434_CR19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1997.15.3.969","volume":"15","author":"CL Loprinzi","year":"1997","unstructured":"Loprinzi CL, Abu-Ghazaleh S, Sloan JA et al (1997) Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 15(3):969\u2013973","journal-title":"J Clin Oncol"},{"issue":"4","key":"3434_CR20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/AOG.0b013e3182118790","volume":"117","author":"YK Lee","year":"2011","unstructured":"Lee YK, Chung HH, Kim JW et al (2011) Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstet Gynecol 117(4):922\u2013927","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3434_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","volume":"87","author":"K Modelska","year":"2002","unstructured":"Modelska K, Cummings S (2002) Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 87(1):16\u201323","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3434_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","volume":"10","author":"P Kenemans","year":"2009","unstructured":"Kenemans P, Bundred NJ, Foidart JM et al (2009) Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10(2):135\u2013146","journal-title":"Lancet Oncol"},{"issue":"4","key":"3434_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.maturitas.2011.09.003","volume":"70","author":"P Sismondi","year":"2011","unstructured":"Sismondi P, Kimmings R, Kubista E et al (2011) Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients\u2014data from LIBERATE trial. Maturitas 70(4):365\u2013372","journal-title":"Maturitas"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3434-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3434-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3434-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3434-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:43:13Z","timestamp":1559234593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3434-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3434"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3434-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,24]]}}}